nimodipine has been researched along with Eye Diseases in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Eye Diseases: Diseases affecting the eye.
Excerpt | Relevance | Reference |
---|---|---|
"Ocular ischaemic syndrome is a progressive and serious vision-threatening condition that is usually associated with carotid artery disease, and poor effective therapeutic options are available." | 1.42 | Reversed ocular ischaemic syndrome secondary to carotid cavernous sinus embolisation. ( Branco, G; Costa, JM; Isidro, F; Reizinho, C, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Isidro, F | 1 |
Reizinho, C | 1 |
Branco, G | 1 |
Costa, JM | 1 |
1 other study available for nimodipine and Eye Diseases
Article | Year |
---|---|
Reversed ocular ischaemic syndrome secondary to carotid cavernous sinus embolisation.
Topics: Aged; Carotid Arteries; Carotid-Cavernous Sinus Fistula; Cavernous Sinus; Embolization, Therapeutic; | 2015 |